24.04.2024 02:29:48 - dpa-AFX: *EUROPEAN COMMISSION APPROVES ASTELLAS' XTANDI FOR RECURRENT EARLY PROSTATE CANCER TREATMENT EXPANSION

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
ASTELLAS PHARMA INC. 856273 Frankfurt 9,152 28.06.24 09:21:19 +0,074 +0,82% 9,094 9,504 9,152 9,078

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH